As China’s healthcare reforms accelerate, and the pace of market growth slows, the position of multinational pharmaceutical companies in China becomes ever more challenging.

What are the drivers of commercial success moving forward? What are the pitfalls to avoid?

In this must-attend session at the 2nd Annual BioCentury China Healthcare Summit, China general managers from AstraZeneca, Pfizer, Roche and Sanofi share their views on navigating changing times in China.

Attendance at this VIP-only meeting is restricted to senior executives, scientists and investors. Seating is limited, so register today to reserve your spot.

This event will take place on October 20-21, 2015 in Shanghai. ChinaBio members can register for 20% off the regular rates by entering the promo code „CHINABIO“. For more information and registration, please visit the event website.

Dieser Post ist auch verfügbar auf: Vereinfachtes Chinesisch